PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New research uncovers molecular ‘safety switch’ shielding cancers from immune attack

Blocking the TAK1 gene could improve the performance of existing cancer immunotherapies

2025-12-19
(Press-News.org)

Australian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may limit the effectiveness of immunotherapy treatments.

Cancer immunotherapies can work very well, but underperform in some cases due to tumours’ inbuilt survival processes that help them resist attack by the immune system.

Researchers at the Olivia Newton-John Cancer Research Institute (ONJCRI) and WEHI discovered that the TAK1 gene acts like a safety switch that protects cancer cells from the powerful signals generated by CD8⁺ T cells.

TAK1 was identified by conducting a large genetic screen to search for genes that help cancer cells survive attacks by CD8⁺ T cells, key killer cells of our immune system.

Dr Anne Huber, Postdoctoral Researcher at ONJCRI, affiliated with La Trobe University as the School of Cancer Medicine, says:

“It is known that TAK1 promotes cancer cell survival and blocks cell death, however we didn’t know that cancer cells use this tactic to avoid killing by the immune system.”

The researchers tested the importance of the TAK1 gene to cancer cell survival by silencing it using CRISPR/Cas9 technology. In pre-clinical models with typical immune function, they found that tumours lacking TAK1 grow poorly, demonstrating that the immune system is able to control cancer cells better.

Dr Huber says: “When TAK1 was blocked, immune signals generated by CD8+ T cells triggered the cancer cell’s self-destruct pathways.

“Without TAK1, the cancer cells lose a key protein, cFLIP, that normally prevents cell death, and they become far more sensitive to immune attack.” 

Turning off TAK1 makes cancer cells much easier for the immune system to eliminate, offering hope for more powerful treatment options in the future.

Dr Tirta (Mario) Djajawi, Postdoctoral Researcher at ONJCRI, says: “Blocking TAK1 could make current immunotherapies more effective by stripping tumours of this protection.

“TAK1 is like a shock absorber that lets cancer cells survive the immune system’s hardest hits. Remove it, and the tumour collapses under the force of immune attack.”

Looking forward, the team will undertake further research into blocking TAK1 using innovative liquid nanoparticle technology and testing the efficacy of existing immunotherapies on cancer cells.

The research was conducted across a variety of cancer types, predominantly melanoma, which is often treated with immunotherapy and is diagnosed in 330,000 people worldwide and causes 60,000 deaths annually (2022 data).[1]

This work was conducted in collaboration with Dr Stephin Vervoort’s laboratory and Sarahi Mendoza Rivera at WEHI. Read the full paper published in Cell Reports.

This work was supported by an NHMRC Investigator grant EL2 (2034017), an NHMRC Ideas grant (2029625), a project grant from Tour de Cure, the CASS Foundation and the Austin Medical Research Fund (AMRF). The Vervoort Lab is proudly supported by the Snow Medical Research Foundation and CSL.

 

 

[1] https://www.iarc.who.int/cancer-type/skin-cancer/

END



ELSE PRESS RELEASES FROM THIS DATE:

Bacteria resisting viral infection can still sink carbon to ocean floor

2025-12-19
COLUMBUS, Ohio – Marine bacteria are key to determining whether carbon is recycled near the ocean surface or transported to deeper waters, but many operate in constant threat of being infected by viruses called phages, and mutate to fend off those infections. The resulting evolutionary arms race between bacteria modifying themselves and viruses fighting back raises questions: What does it cost a cell to resist infections, and how does that alter how ecosystems function? In a new study, researchers ...

Younger biological age may increase depression risk in older women during COVID-19

2025-12-19
“Epigenetic age is a biological metric of overall health and may predict mental health responses to unprecedented stressors.” BUFFALO, NY — December 19, 2025 — A new research paper was published in Volume 17, Issue 11 of Aging-US on November 18, 2025, titled “Epigenetic age predicts depressive symptoms during the COVID-19 pandemic in the Canadian Longitudinal Study on Aging: importance of biological sex.” This study, led by Cindy K. Barha of the University of Calgary and the University of British Columbia, along with Teresa Liu-Ambrose of the University ...

Bharat Innovates 2026 National Basecamp Showcases India’s Most Promising Deep-Tech Ventures

2025-12-19
The Bharat Innovates 2026 National Basecamp was formally inaugurated today at the Indian Institute of Technology Gandhinagar (IITGN), marking a significant milestone in India’s efforts to identify, strengthen, and globally position its most promising deep-tech innovations. The three-day National Basecamp, taking place from December 18 to 20, 2025, brings together approximately 400 shortlisted startups and research-led innovations that have been selected through a rigorous, multi-stage national screening process. The shortlisted startups and innovators are some of India’s brightest and most impactful, with the potential to ...

Here’s what determines whether your income level rises or falls

2025-12-19
Economists call it “income mobility”. This means how easy or difficult it is for you or your family to go up or down in income compared to others in the community around you. People in Norway have a high level of income mobility. It is quite possible for people to increase their incomes. But also for those incomes to drop. “Your income is the sum of what you earn from work and from capital income,” says Professor Roberto Iacono at the Norwegian University of Science and Technology's ...

SCIE indexation achievement: Celebrate with Space: Science & Technology

2025-12-19
On December 8, 2025, Space: Science & Technology was officially indexed in the Web of Science: Science Citation Index Expanded (SCIE). All articles published since 2021 will be progressively included into the SCIE database. The editorial team would love to extend our heartfelt gratitude to the hosts of the journal: Beijing Institute of Technology and the China Academy of Space Technology, as well as to Editor-in-Chief Prof. YE Peijian, member of the Chinese Academy of Sciences, the entire Editorial Board, all authors and reviewers for their invaluable contributions. We also sincerely thank all ...

Children’s Hospital Colorado performs region’s first pediatric heart and liver dual organ transplant

2025-12-19
AURORA, Colo. (Dec. 19, 2025) – Children’s Hospital Colorado (Children’s Colorado) successfully performed the hospital’s first-ever heart and liver dual organ transplant, with support from dozens of team members across 25 different multidisciplinary care teams. Only 38 other pediatric heart and liver dual organ transplants have been completed in the United States.    “Performing Children’s Colorado’s first-ever heart and liver dual organ transplant is an amazing accomplishment for our Pediatric Transplant Program,” said Dr. Megan Adams, surgical director of the Pediatric Liver Transplant and Kidney Transplant Programs. ...

Australian team discover why quantum computers have memory problems over time

2025-12-19
A team of Australian and international scientists has, for the first time, created a full picture of how errors unfold over time inside a quantum computer — a breakthrough that could help make future quantum machines far more reliable.   The researchers, led by Macquarie University’s Dr Christina Giarmatzi, found that the tiny errors that plague quantum computers don’t just appear randomly. Instead, they can linger, evolve and even link together across different moments in time.   “We can think of it as quantum computers retaining memory of the errors, which ...

What determines the fate of a T cell?

2025-12-19
Researchers at the Max Delbrück Center have found that a cellular housekeeping mechanism called autophagy plays a major role in ensuring that T stem cells undergo normal cell division. The findings, published in “Nature Cell Biology,” could help boost vaccine response in older adults. When killer T cells of our immune system divide, they normally undergo asymmetric cell division (ACD): Each daughter cell inherits different cellular components, which drive the cells toward divergent fates – one cell becomes a ...

Candida auris: genetic process revealed which could be treatment target for deadly fungal disease

2025-12-19
Scientists have discovered a genetic process which could unlock new ways to treat mysterious and deadly fungal infection which has shut down multiple hospital intensive care units. Candida auris is particularly dangerous for people who are critically ill, so hospitals are vulnerable. While it seems to live harmlessly on the skin of increasing numbers of people, patients on ventilators are at high risk.  Once infected, the disease has a death rate of 45 per cent, and can resist all major classes of antifungal drugs, making it extremely difficult to treat and eradicate from wards, once patients are infected. The disease was only detected in 2008, and its origins remain ...

Groundbreaking discovery turns household plastic recycling into anti-cancer medication 

2025-12-19
A groundbreaking discovery  led by the University of St Andrews has found a way to turn ordinary household plastic waste into the building block for anti-cancer drugs.   Household PET (polyethylene terephthalate) waste, such as plastic bottles and textiles, can be recycled in two main ways: mechanically or chemically. Chemical recycling breaks down PET’s long polymer chains into individual units called monomers or into other valuable chemicals.  Published today (Thursday 18 December) ...

LAST 30 PRESS RELEASES:

The Lancet: First-ever in-utero stem cell therapy for fetal spina bifida repair is safe, study finds

Nanoplastics can interact with Salmonella to affect food safety, study shows

Eric Moore, M.D., elected to Mayo Clinic Board of Trustees

NYU named “research powerhouse” in new analysis

New polymer materials may offer breakthrough solution for hard-to-remove PFAS in water

Biochar can either curb or boost greenhouse gas emissions depending on soil conditions, new study finds

Nanobiochar emerges as a next generation solution for cleaner water, healthier soils, and resilient ecosystems

Study finds more parents saying ‘No’ to vitamin K, putting babies’ brains at risk

Scientists develop new gut health measure that tracks disease

Rice gene discovery could cut fertiliser use while protecting yields

Jumping ‘DNA parasites’ linked to early stages of tumour formation

Ultra-sensitive CAR T cells provide potential strategy to treat solid tumors

Early Neanderthal-Human interbreeding was strongly sex biased

North American bird declines are widespread and accelerating in agricultural hotspots

Researchers recommend strategies for improved genetic privacy legislation

How birds achieve sweet success

More sensitive cell therapy may be a HIT against solid cancers

Scientists map how aging reshapes cells across the entire mammalian body

Hotspots of accelerated bird decline linked to agricultural activity

How ancient attraction shaped the human genome

NJIT faculty named Senior Members of the National Academy of Inventors

App aids substance use recovery in vulnerable populations

College students nationwide received lifesaving education on sudden cardiac death

Oak Ridge National Laboratory launches the Next-Generation Data Centers Institute

Improved short-term sea level change predictions with better AI training

UAlbany researchers develop new laser technique to test mRNA-based therapeutics

New water-treatment system removes nitrogen, phosphorus from farm tile drainage

Major Canadian study finds strong link between cannabis, anxiety and depression

New discovery of younger Ediacaran biota

Lymphovenous bypass: Potential surgical treatment for Alzheimer's disease?

[Press-News.org] New research uncovers molecular ‘safety switch’ shielding cancers from immune attack
Blocking the TAK1 gene could improve the performance of existing cancer immunotherapies